Ac-DEVD-CHO

CAS No. 169332-60-9

Ac-DEVD-CHO( —— )

Catalog No. M37941 CAS No. 169332-60-9

Ac-DEVD-CHO is a specific Caspase-3 inhibitor (Ki: 230 pM) with inhibitory effects on SLNT-induced apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 103 Get Quote
5MG 225 Get Quote
10MG 332 Get Quote
25MG 545 Get Quote
50MG 777 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ac-DEVD-CHO
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac-DEVD-CHO is a specific Caspase-3 inhibitor (Ki: 230 pM) with inhibitory effects on SLNT-induced apoptosis.
  • Description
    Ac-DEVD-CHO is a specific Caspase-3 inhibitor with a Ki value of 230 pM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | Caspase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    169332-60-9
  • Formula Weight
    502.47
  • Molecular Formula
    C20H30N4O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : ≥ 50 mg/mL (99.51 mM)
  • SMILES
    [H][C@@](CC(O)=O)(NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CCC(O)=O)NC(=O)[C@]([H])(CC(O)=O)NC(C)=O)C(C)C)C=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Garcia-Calvo M, et al.nhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem.1998 Dec 4;273(49):32608-13.?
molnova catalog
related products
  • Diethyl phthalate

    Diethyl phthalate is a endocrine disrupter affecting the apoptotic system in PC12 cells. Diethyl phthalate is widely used in many plastics and personal care products.

  • Exisulind

    Exisulind induces apoptosis through the activation of protein kinase G (PKG). Exisulind exhibits antineoplastic activity in solid tumour and haematological cancer cell lines and is an inhibitor of tumour growth in rodent models of colon, prostate, bladder, mammary and lung cancer.

  • Tafasitamab

    Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell lymphoma.